SLF1 polymorphism predicts response to oxaliplatin-based adjuvant chemotherapy in patients with colon cancer

Response to oxaliplatin-based adjuvant chemotherapy varies among patients with stage II and III colon cancer; however, genetic alterations associated with this response remain incompletely characterized. A three-stage analytical framework, including the discovery, validation, and replication stages,...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Cancer Res
Главные авторы: Han, Xiaohong, Wang, Zheng, Zhang, Lei, Shen, Yinchen, Tan, Qiaoyun, Sun, Yongkun, Wang, Jianfei, Qian, Xiaoyan, Yang, Hongying, Shi, Yuankai
Формат: Artigo
Язык:Inglês
Опубликовано: e-Century Publishing Corporation 2021
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8085871/
https://ncbi.nlm.nih.gov/pubmed/33948371
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы